(Q40684175)

22 September 2017

title

Inhibition of cdk2 activating phosphorylation by mevastatin (English)

1 reference

22 September 2017

1 reference

2

1 reference

22 September 2017

Chinweike Ukomadu

1

1 reference

22 September 2017

language of work or name

English

0 references

publication date

9 December 2002

1 reference

Journal of Biological Chemistry

22 September 2017

published in

1 reference

22 September 2017

volume

278

1 reference

22 September 2017

issue

7

1 reference

22 September 2017

page(s)

4840-4846

1 reference

Principles of CDK regulation

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Results of intensive long-term treatment of familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Proteasome inhibitors alter the orderly progression of DNA synthesis during S-phase in HeLa cells and lead to rereplication of DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

The Cdk-activating kinase (CAK) from budding yeast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Cdk-activating kinase complex is a component of human transcription factor TFIIH

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M208658200

21 January 2018

Identifiers

DOI

10.1074/JBC.M208658200

1 reference

22 September 2017

1 reference